InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Patel Mahesh V., Chairman & CEO. Director active across 1 company, notably Lipocine Inc.. In total, 3 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €85k. History available since 18 November 2021. The latest transaction was disclosed on 16 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
50,000 shares@ US$0.76990.20% mcap43.4% of flowCommon StockSEC:0001493152-22-014014:0
Ideal exit: 10 Feb 2023 (T+270)
25,000 shares@ US$1.09100.0% of flowCommon StockSEC:0001493152-21-029268
Ideal exit: 15 Aug 2022 (T+270)
25,000 shares@ US$1.090.13% mcap28.3% of flowCommon StockSEC:0001493152-21-029268:0
Ideal exit: 15 Aug 2022 (T+270)
3 of 3 declarations
About Patel Mahesh V.
Mahesh V. Patel is the CEO and President of Lipocine Inc. He leads the company focused on developing innovative pharmaceutical treatments. His role is essential in guiding the strategy and ensuring the growth of Lipocine.
